Mahamaya Drugs And Cosmetics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 11-12-2024
- Paid Up Capital ₹ 0.49 M
as on 11-12-2024
- Company Age 17 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
About Mahamaya Drugs And Cosmetics
The Corporate was formerly known as Sun Biolab Private Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.49 M, as per Ministry of Corporate Affairs (MCA) records.
Sant Niranjan and Abhishek Niranjan serve as directors at the Company.
- CIN/LLPIN
U51397UP2007PTC034195
- Company No.
034195
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Nov 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Jalaun, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Mahamaya Drugs And Cosmetics Private Limited offer?
Mahamaya Drugs And Cosmetics Private Limited offers a wide range of products and services, including Popular Category, Sexual Wellness.
Who are the key members and board of directors at Mahamaya Drugs And Cosmetics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sant Niranjan  | Director | 27-Nov-2007 | Current |
| Abhishek Niranjan | Director | 21-Apr-2018 | Current |
Financial Performance of Mahamaya Drugs And Cosmetics.
Mahamaya Drugs And Cosmetics Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mahamaya Drugs And Cosmetics?
In 2017, Mahamaya Drugs And Cosmetics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Glector Global Enterprises Private LimitedActive 9 years 11 monthsAbhishek Niranjan is a mutual person
- Mansarovar Krishi Chetna Producer Company LimitedActive 2 years 5 months
Abhishek Niranjan is a mutual person
- Man Sarovar Food Processing Private LimitedActive 23 years 1 month
Abhishek Niranjan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mahamaya Drugs And Cosmetics?
Unlock and access historical data on people associated with Mahamaya Drugs And Cosmetics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mahamaya Drugs And Cosmetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mahamaya Drugs And Cosmetics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
